Return
Correction: The dynamic evolution of circulating tumor cells during glecirasib treatment predicts survival and resistance in gastrointestinal tumors with KRASG12C mutation
L
Y
X
Y
Y
Z
T
H
Z
L
Y
W
J
DOI:10.1007/s13577-026-01434-9.png)
Abstract
En
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
3.1
Papers:
1.5K
Citations:
2.7K
